+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Cocrystal Pharma Inc (COCP) - Financial and Strategic SWOT Analysis Review

  • ID: 4284768
  • SWOT Analysis
  • 25 pages
  • GlobalData
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 3

Cocrystal Pharma Inc (Cocrystal Pharma), formerly Biozone Pharmaceuticals Inc, a subsidiary of MusclePharm Corp, is a pharmaceutical company that develops novel antiviral therapeutics. The company provides treatments for chronic viral diseases. Its pipeline products include Nucleoside NS5B, NS5A, NNI NS5B, and NS3 Helicase. Cocrystal Pharma provides products such as non nucleoside inhibitors, novel pan-genotypic nucleoside prodrugs, and helicase inhibitors. The company’s novel pan-genotypic nucleoside pro-drugs are used in non-toxic, resisting drug-drug interactions, barrier to drug resistance, short duration treatment and others. Its novel antiviral therapeutics is used in treatments for serious and chronic viral diseases. The company operates in Tucker and Bothell, the US. Cocrystal Pharma is headquartered in Tucker, Georgia, the US.

Cocrystal Pharma Inc Key Recent Developments

Nov 08, 2017: Cocrystal Pharma Announces Filing 2017 Third Quarter Financial Statements and Provides Company Update
Aug 08, 2017: Cocrystal Pharma Announces Filing 2017 Second Quarter Financial Statements and Provides Company Update
Jun 01, 2017: James J. Martin Appointed as Chief Financial Officer of Cocrystal Pharma
Apr 03, 2017: Cocrystal Pharma Reports Financial Results for Fourth Quarter & Year Ended December 31, 2016 and Provides Company Update

This comprehensive SWOT profile of Cocrystal Pharma Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of the author’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, the author’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Cocrystal Pharma Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
*Note: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Product cover images may vary from those shown
2 of 3
Section 1 - About the Company
  • Cocrystal Pharma Inc - Key Information
  • Cocrystal Pharma Inc - Overview
  • Cocrystal Pharma Inc - Key Employees
  • Cocrystal Pharma Inc - Key Employee Biographies
  • Cocrystal Pharma Inc - Key Operational Heads
  • Cocrystal Pharma Inc - Major Products and Services
  • Cocrystal Pharma Inc - History
  • Cocrystal Pharma Inc - Company Statement
  • Cocrystal Pharma Inc - Locations And Subsidiaries
  • Cocrystal Pharma Inc - Key Manufacturing facilities
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Cocrystal Pharma Inc - Business Description
  • Cocrystal Pharma Inc - Corporate Strategy
  • Cocrystal Pharma Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • Cocrystal Pharma Inc - Strengths
  • Cocrystal Pharma Inc - Weaknesses
  • Cocrystal Pharma Inc - Opportunities
  • Cocrystal Pharma Inc - Threats
  • Cocrystal Pharma Inc - Key Competitors
Section 3 - Company Financial Performance Charts
  • Cocrystal Pharma Inc - Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Appendix
  • Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
*Note: Some sections may be missing if data is unavailable for the company

List of Tables
  • Cocrystal Pharma Inc, Key Information
  • Cocrystal Pharma Inc, Key Ratios
  • Cocrystal Pharma Inc, Share Data
  • Cocrystal Pharma Inc, Major Products and Services
  • Cocrystal Pharma Inc, History
  • Cocrystal Pharma Inc, Key Employees
  • Cocrystal Pharma Inc, Key Employee Biographies
  • Cocrystal Pharma Inc, Key Operational Heads
  • Cocrystal Pharma Inc, Other Locations
  • Cocrystal Pharma Inc, Subsidiaries
  • Cocrystal Pharma Inc, Key Manufacturing facilities
  • Cocrystal Pharma Inc, Key Competitors
  • Cocrystal Pharma Inc, SWOT Analysis
  • Cocrystal Pharma Inc, Ratios based on current share price
  • Cocrystal Pharma Inc, Annual Ratios
  • Cocrystal Pharma Inc, Interim Ratios
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Cocrystal Pharma Inc, Performance Chart
  • Cocrystal Pharma Inc, Ratio Charts
Note: Product cover images may vary from those shown
3 of 3